122 related articles for article (PubMed ID: 38279461)
1. Evaluation of use of hyperbaric oxygen in suppression of hyper-proliferation in hypoxic NSCLC cells.
Chen JR; Khan H; Umarzai Y; Rajput A; Mamund T
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):132-136. PubMed ID: 38279461
[TBL] [Abstract][Full Text] [Related]
2. Hyperbaric Oxygen Therapy Represses the Warburg Effect and Epithelial-Mesenchymal Transition in Hypoxic NSCLC Cells
Zhang L; Ke J; Min S; Wu N; Liu F; Qu Z; Li W; Wang H; Qian Z; Wang X
Front Oncol; 2021; 11():691762. PubMed ID: 34367973
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia.
Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
Life Sci; 2020 Aug; 255():117826. PubMed ID: 32450163
[TBL] [Abstract][Full Text] [Related]
4. Hyperbaric oxygen rescues lung cancer cells from chemical hypoxia-induced low differentiation and apoptosis resistance.
Wang Y; Qi Y; Wei X; Chen S; Jia N; Zhou Q; Zhang S; Gui S; Wang Y
Exp Lung Res; 2018; 44(8-9):417-423. PubMed ID: 30739528
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells.
Mi YJ; Geng GJ; Zou ZZ; Gao J; Luo XY; Liu Y; Li N; Li CL; Chen YQ; Yu XY; Jiang J
PLoS One; 2015; 10(3):e0120426. PubMed ID: 25799586
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
8. Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer.
Chen SY; Tsuneyama K; Yen MH; Lee JT; Chen JL; Huang SM
Sci Rep; 2021 Jun; 11(1):12033. PubMed ID: 34103583
[TBL] [Abstract][Full Text] [Related]
9. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
10. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
Wang Q; Wu H; Wu Q; Zhong S
Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
[TBL] [Abstract][Full Text] [Related]
11. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
12. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
[TBL] [Abstract][Full Text] [Related]
13. Hyperbaric oxygen therapy activates hypoxia-inducible factor 1 (HIF-1), which contributes to improved wound healing in diabetic mice.
Sunkari VG; Lind F; Botusan IR; Kashif A; Liu ZJ; Ylä-Herttuala S; Brismar K; Velazquez O; Catrina SB
Wound Repair Regen; 2015; 23(1):98-103. PubMed ID: 25532619
[TBL] [Abstract][Full Text] [Related]
14. Cyclophilin a represses reactive oxygen species generation and death of hypoxic non-small-cell lung cancer cells by degrading thioredoxin-interacting protein.
Li Y; Yang L
Cell Cycle; 2022 Sep; 21(18):1996-2007. PubMed ID: 35579671
[TBL] [Abstract][Full Text] [Related]
15. miR-16-5p regulates aerobic glycolysis and tumorigenesis of NSCLC cells via LDH-A/lactate/NF-κB signaling.
Arora S; Singh P; Tabassum G; Dohare R; Syed MA
Life Sci; 2022 Sep; 304():120722. PubMed ID: 35714705
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells.
Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
Eur J Pharmacol; 2019 Nov; 862():172615. PubMed ID: 31422060
[TBL] [Abstract][Full Text] [Related]
17. Functional regulation of osteoblastic MC3T3E-1 cells by hyperbaric oxygen treatment.
Kaku M; Izumino J; Yamamoto T; Yashima Y; Shimoe S; Tanimoto K
Arch Oral Biol; 2022 Jun; 138():105410. PubMed ID: 35305478
[TBL] [Abstract][Full Text] [Related]
18. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results.
Ohguri T; Imada H; Narisada H; Yahara K; Morioka T; Nakano K; Miyaguni Y; Korogi Y
Int J Hyperthermia; 2009 Mar; 25(2):160-7. PubMed ID: 19337916
[TBL] [Abstract][Full Text] [Related]
19. Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non‑small cell lung cancer.
Wang F; Li L; Zhang Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236133
[TBL] [Abstract][Full Text] [Related]
20. Hyperbaric oxygen activates visfatin expression and angiogenesis via angiotensin II and JNK pathway in hypoxic human coronary artery endothelial cells.
Chiu CZ; Wang BW; Yu YJ; Shyu KG
J Cell Mol Med; 2020 Feb; 24(4):2434-2443. PubMed ID: 31957305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
